← back to search

Richard E. Hillman

University of Missouri · US

Area of research

Clinical Biochemistry · Biochemistry

Research interest

Research interests include Enzyme replacement therapy, Medicine, Internal medicine, Immunogenicity, and Glycogen storage disease type II.

h-index

—

citations

31

works

1

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study

Genetics in Medicine 2018cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2018–2018)Catherine Wilson · The University of Western Australia1 papers (2018–2018)Raymond Wang · Massachusetts Institute of Technology1 papers (2018–2018)Priya S. Kishnani · University of Kentucky1 papers (2018–2018)— · 1 papers (2018–2018)Yang Zhao · London School of Hygiene & Tropical Medicine1 papers (2018–2018)Michael J. Gambello · Emory University1 papers (2018–2018)— · 1 papers (2018–2018)Susan Sparks · KU Leuven1 papers (2018–2018)— · 1 papers (2018–2018)Si Houn Hahn · Seattle Children's Hospital1 papers (2018–2018)Loren Peña · Cincinnati Children's Hospital Medical Center1 papers (2018–2018)James B. Gibson · The Ohio State University1 papers (2018–2018)— · 1 papers (2018–2018)David Kronn · New York Medical College1 papers (2018–2018)